SCHEMBL14638925

SCHEMBL14638925

COC(=O)C(=[N+]=[N-])c1ccc(I)c(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 4/20 0.38
▸ TAS1R1 Q7RTX1 4/20 0.38
▸ TAS1R2 Q8TE23 3/20 0.38
▸ ALDH1A1 P00352 5/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ GAA P10253 1/20 0.36
▸ HPGD P15428 2/20 0.35
▸ MEN1 O00255 4/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ RAB9A P51151 3/20 0.34
▸ LMNA P02545 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2651614 0.86 HPGD (0.48) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL29782139 0.86 HPGD (0.48) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL2653478 0.79 VCAM1 (0.39) TAS1R3TAS1R1TAS1R2ALDH1A1KDM4E
SCHEMBL14638953 0.78 TPMT (0.41) ALDH1A1KDM4EL3MBTL1MAPT
SCHEMBL926435 0.78 HPGD (0.44) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL1528984 0.76 ALDH1A1 (0.54) ALDH1A1KDM4EGAAHPGDMEN1
SCHEMBL21804733 0.76 PARP1 (0.46) ALDH1A1HPGDMEN1KMT2ARAB9A
SCHEMBL30031180 0.76 PARP1 (0.46) ALDH1A1HPGDMEN1KMT2ARAB9A
SCHEMBL13734747 0.74 TSHR (0.56) ALDH1A1KDM4EGAAHPGDMEN1
SCHEMBL21807136 0.73 ALDH1A1 (0.36) TAS1R3TAS1R1TAS1R2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10093609-B2 TAK1 kinase inhibitors, compositions, and uses related thereto EMORY UNIVERSITY (US) 2018-10-09 — — US disclosed
US-20170369417-A1 TAK1 Kinase Inhibitors, Compositions, and Uses Related Thereto NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-12-28 — — US disclosed
US-9751825-B2 TAK1 kinase inhibitors, compositions, and used related thereto EMORY UNIVERSITY (US) 2017-09-05 — — US disclosed
US-20140249199-A1 TAK1 KINASE INHIBITORS, COMPOSITIONS, AND USED RELATED THERETO HEALTH RESEARCH, INC. (US) 2014-09-04 — — US disclosed
WO-2013012998-A1 TAK1 KINASE INHIBITORS, COMPOSITIONS, AND USED RELATED THERETO EMORY UNIVERSITY (US) 2013-01-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10093609-B2 TAK1 kinase inhibitors, compositions, and uses related thereto TAB1, MAP3K1, MAP3K6 TAS1R3 3762/4885TAS1R1 3383/4885TAS1R2 4042/4885
US-20140249199-A1 TAK1 KINASE INHIBITORS, COMPOSITIONS, AND USED RELATED THERETO TAB1, MAP3K1, MAP3K6 TAS1R3 3638/4885TAS1R1 3245/4885TAS1R2 3948/4885
US-20170369417-A1 TAK1 Kinase Inhibitors, Compositions, and Uses Related Thereto TAB1, MAP3K1, MAP3K6 TAS1R3 3762/4885TAS1R1 3383/4885TAS1R2 4042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback